PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RSPN vs. BIS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


RSPNBIS
YTD Return8.91%-1.13%
1Y Return29.44%-12.87%
3Y Return (Ann)9.01%-6.66%
5Y Return (Ann)16.04%-24.66%
10Y Return (Ann)12.25%-24.95%
Sharpe Ratio2.24-0.27
Daily Std Dev13.34%33.44%
Max Drawdown-59.17%-99.76%
Current Drawdown-1.82%-99.72%

Correlation

-0.50.00.51.0-0.5

The correlation between RSPN and BIS is -0.50. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.

Performance

RSPN vs. BIS - Performance Comparison

In the year-to-date period, RSPN achieves a 8.91% return, which is significantly higher than BIS's -1.13% return. Over the past 10 years, RSPN has outperformed BIS with an annualized return of 12.25%, while BIS has yielded a comparatively lower -24.95% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-100.00%0.00%100.00%200.00%300.00%400.00%500.00%December2024FebruaryMarchAprilMay
506.06%
-99.62%
RSPN
BIS

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Invesco S&P 500® Equal Weight Industrials ETF

ProShares UltraShort Nasdaq Biotechnology

RSPN vs. BIS - Expense Ratio Comparison

RSPN has a 0.40% expense ratio, which is lower than BIS's 0.95% expense ratio.


BIS
ProShares UltraShort Nasdaq Biotechnology
Expense ratio chart for BIS: current value at 0.95% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.95%
Expense ratio chart for RSPN: current value at 0.40% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.40%

Risk-Adjusted Performance

RSPN vs. BIS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco S&P 500® Equal Weight Industrials ETF (RSPN) and ProShares UltraShort Nasdaq Biotechnology (BIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RSPN
Sharpe ratio
The chart of Sharpe ratio for RSPN, currently valued at 2.24, compared to the broader market0.002.004.006.002.24
Sortino ratio
The chart of Sortino ratio for RSPN, currently valued at 3.19, compared to the broader market0.005.0010.003.19
Omega ratio
The chart of Omega ratio for RSPN, currently valued at 1.39, compared to the broader market0.501.001.502.002.503.001.39
Calmar ratio
The chart of Calmar ratio for RSPN, currently valued at 2.19, compared to the broader market0.005.0010.0015.002.19
Martin ratio
The chart of Martin ratio for RSPN, currently valued at 6.79, compared to the broader market0.0020.0040.0060.0080.00100.006.79
BIS
Sharpe ratio
The chart of Sharpe ratio for BIS, currently valued at -0.27, compared to the broader market0.002.004.006.00-0.27
Sortino ratio
The chart of Sortino ratio for BIS, currently valued at -0.17, compared to the broader market0.005.0010.00-0.17
Omega ratio
The chart of Omega ratio for BIS, currently valued at 0.98, compared to the broader market0.501.001.502.002.503.000.98
Calmar ratio
The chart of Calmar ratio for BIS, currently valued at -0.09, compared to the broader market0.005.0010.0015.00-0.09
Martin ratio
The chart of Martin ratio for BIS, currently valued at -0.43, compared to the broader market0.0020.0040.0060.0080.00100.00-0.43

RSPN vs. BIS - Sharpe Ratio Comparison

The current RSPN Sharpe Ratio is 2.24, which is higher than the BIS Sharpe Ratio of -0.27. The chart below compares the 12-month rolling Sharpe Ratio of RSPN and BIS.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50December2024FebruaryMarchAprilMay
2.24
-0.27
RSPN
BIS

Dividends

RSPN vs. BIS - Dividend Comparison

RSPN's dividend yield for the trailing twelve months is around 0.98%, less than BIS's 2.68% yield.


TTM20232022202120202019201820172016201520142013
RSPN
Invesco S&P 500® Equal Weight Industrials ETF
0.98%1.06%1.09%0.70%0.96%1.33%1.49%1.12%1.31%1.51%1.27%0.90%
BIS
ProShares UltraShort Nasdaq Biotechnology
2.68%1.75%0.00%0.00%0.44%2.11%0.37%0.00%0.00%0.00%0.00%0.00%

Drawdowns

RSPN vs. BIS - Drawdown Comparison

The maximum RSPN drawdown since its inception was -59.17%, smaller than the maximum BIS drawdown of -99.76%. Use the drawdown chart below to compare losses from any high point for RSPN and BIS. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-1.82%
-99.72%
RSPN
BIS

Volatility

RSPN vs. BIS - Volatility Comparison

The current volatility for Invesco S&P 500® Equal Weight Industrials ETF (RSPN) is 3.19%, while ProShares UltraShort Nasdaq Biotechnology (BIS) has a volatility of 9.39%. This indicates that RSPN experiences smaller price fluctuations and is considered to be less risky than BIS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%December2024FebruaryMarchAprilMay
3.19%
9.39%
RSPN
BIS